 | • レポートコード：QY2108PAL8874 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるインターフェロンの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、インターフェロンの種類別市場規模（長持ち、一般）、用途別市場規模（肝炎、多発性硬化症、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のインターフェロン市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるインターフェロンの種類別市場規模（2016年-2027年）：長持ち、一般 ・世界におけるインターフェロンの用途別市場規模（2016年-2027年）：肝炎、多発性硬化症、その他 ・インターフェロンの中国市場分析 - インターフェロンの中国市場規模（2016年-2027年） - 中国におけるインターフェロンの主要プレイヤー別市場シェア - 中国におけるインターフェロンの種類別市場規模：長持ち、一般 - 中国におけるインターフェロンの用途別市場規模：肝炎、多発性硬化症、その他 ・インターフェロンの北米市場（2016年-2027年） ・インターフェロンのヨーロッパ市場（2016年-2027年） ・インターフェロンのアジア太平洋市場（2016年-2027年） ・インターフェロンの中南米市場（2016年-2027年） ・インターフェロンの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Roche、Anke Biotechnology、Bayer、Merck & Co、Tri-Prime、Kawin、Genzon Pharma、Novartis、Biogen、Merck KGaA、Zydus Cadila、Huaxin Biotechnology、Harbin Pharmaceutical ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Interferons (IFNs) are a group of signaling proteins made and released by host cells in response to the presence of several pathogens, such as viruses, bacteria, parasites, and also tumor cells. In a typical scenario, a virus-infected cell will release interferons causing nearby cells to heighten their anti-viral defenses.
In Asia-Pacific, Interferon key players include Roche, Anke Biotechnology, Tri-Prime, etc. Asia-Pacific top three manufacturers hold a share about 40%.
In terms of product, Long-lasting Type is the largest segment of Cobalt, with a share about 90%. And in terms of application, the largest application is Hepatitis, followed by Multiple Sclerosis.
Market Analysis and Insights: Global and China Interferon Market
This report focuses on global and China Interferon market.
In 2020, the global Interferon market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Interferon market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Interferon Scope and Market Size
Interferon market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Interferon market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Interferon market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Long-lasting Type
Ordinary Type
Segment by Application
Hepatitis
Multiple Sclerosis
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche
Anke Biotechnology
Bayer
Merck & Co
Tri-Prime
Kawin
Genzon Pharma
Novartis
Biogen
Merck KGaA
Zydus Cadila
Huaxin Biotechnology
Harbin Pharmaceutical
1 Study Coverage
1.1 Interferon Product Introduction
1.2 Market by Type
1.2.1 Global Interferon Market Size Growth Rate by Type
1.2.2 Long-lasting Type
1.2.3 Ordinary Type
1.3 Market by Application
1.3.1 Global Interferon Market Size Growth Rate by Application
1.3.2 Hepatitis
1.3.3 Multiple Sclerosis
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Interferon Market Size, Estimates and Forecasts
2.1.1 Global Interferon Revenue 2016-2027
2.1.2 Global Interferon Sales 2016-2027
2.2 Global Interferon, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Interferon Historical Market Size by Region (2016-2021)
2.3.1 Global Interferon Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Interferon Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Interferon Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Interferon Sales Forecast by Region (2022-2027)
2.4.2 Global Interferon Revenue Forecast by Region (2022-2027)
3 Global Interferon Competitor Landscape by Players
3.1 Global Top Interferon Manufacturers by Sales
3.1.1 Global Interferon Sales by Manufacturer (2016-2021)
3.1.2 Global Interferon Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Interferon Manufacturers by Revenue
3.2.1 Key Interferon Manufacturers Covered: Ranking by Revenue
3.2.2 Global Interferon Revenue by Manufacturers (2016-2021)
3.2.3 Global Interferon Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Interferon Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Interferon Revenue in 2020
3.2.6 Global Interferon Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Interferon Price by Manufacturers
3.4 Global Interferon Manufacturing Base Distribution, Product Types
3.4.1 Interferon Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Interferon Product Type
3.4.3 Date of International Manufacturers Enter into Interferon Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Interferon Market Size by Type (2016-2021)
4.1.1 Global Interferon Sales by Type (2016-2021)
4.1.2 Global Interferon Revenue by Type (2016-2021)
4.1.3 Interferon Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Interferon Market Size Forecast by Type (2022-2027)
4.2.1 Global Interferon Sales Forecast by Type (2022-2027)
4.2.2 Global Interferon Revenue Forecast by Type (2022-2027)
4.2.3 Interferon Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Interferon Market Size by Application (2016-2021)
5.1.1 Global Interferon Sales by Application (2016-2021)
5.1.2 Global Interferon Revenue by Application (2016-2021)
5.1.3 Interferon Price by Application (2016-2021)
5.2 Interferon Market Size Forecast by Application (2022-2027)
5.2.1 Global Interferon Sales Forecast by Application (2022-2027)
5.2.2 Global Interferon Revenue Forecast by Application (2022-2027)
5.2.3 Global Interferon Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Interferon Market Size YoY Growth 2016-2027
6.1.1 China Interferon Sales YoY Growth 2016-2027
6.1.2 China Interferon Revenue YoY Growth 2016-2027
6.1.3 China Interferon Market Share in Global Market 2016-2027
6.2 China Interferon Market Size by Players (International and Local Players)
6.2.1 China Top Interferon Players by Sales (2016-2021)
6.2.2 China Top Interferon Players by Revenue (2016-2021)
6.3 China Interferon Historic Market Review by Type (2016-2021)
6.3.1 China Interferon Sales Market Share by Type (2016-2021)
6.3.2 China Interferon Revenue Market Share by Type (2016-2021)
6.3.3 China Interferon Price by Type (2016-2021)
6.4 China Interferon Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Interferon Sales Forecast by Type (2022-2027)
6.4.2 China Interferon Revenue Forecast by Type (2022-2027)
6.4.3 China Interferon Price Forecast by Type (2022-2027)
6.5 China Interferon Historic Market Review by Application (2016-2021)
6.5.1 China Interferon Sales Market Share by Application (2016-2021)
6.5.2 China Interferon Revenue Market Share by Application (2016-2021)
6.5.3 China Interferon Price by Application (2016-2021)
6.6 China Interferon Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Interferon Sales Forecast by Application (2022-2027)
6.6.2 China Interferon Revenue Forecast by Application (2022-2027)
6.6.3 China Interferon Price Forecast by Application (2022-2027)
7 North America
7.1 North America Interferon Market Size YoY Growth 2016-2027
7.2 North America Interferon Market Facts & Figures by Country
7.2.1 North America Interferon Sales by Country (2016-2021)
7.2.2 North America Interferon Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Interferon Market Size YoY Growth 2016-2027
8.2 Asia Pacific Interferon Market Facts & Figures by Region
8.2.1 Asia Pacific Interferon Sales by Region (2016-2021)
8.2.2 Asia Pacific Interferon Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Interferon Market Size YoY Growth 2016-2027
9.2 Europe Interferon Market Facts & Figures by Country
9.2.1 Europe Interferon Sales by Country (2016-2021)
9.2.2 Europe Interferon Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Interferon Market Size YoY Growth 2016-2027
10.2 Latin America Interferon Market Facts & Figures by Country
10.2.1 Latin America Interferon Sales by Country (2016-2021)
10.2.2 Latin America Interferon Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Interferon Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Interferon Market Facts & Figures by Country
11.2.1 Middle East and Africa Interferon Sales by Country (2016-2021)
11.2.2 Middle East and Africa Interferon Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Interferon Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Interferon Products Offered
12.1.5 Roche Recent Development
12.2 Anke Biotechnology
12.2.1 Anke Biotechnology Corporation Information
12.2.2 Anke Biotechnology Description and Business Overview
12.2.3 Anke Biotechnology Interferon Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Anke Biotechnology Interferon Products Offered
12.2.5 Anke Biotechnology Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Description and Business Overview
12.3.3 Bayer Interferon Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer Interferon Products Offered
12.3.5 Bayer Recent Development
12.4 Merck & Co
12.4.1 Merck & Co Corporation Information
12.4.2 Merck & Co Description and Business Overview
12.4.3 Merck & Co Interferon Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck & Co Interferon Products Offered
12.4.5 Merck & Co Recent Development
12.5 Tri-Prime
12.5.1 Tri-Prime Corporation Information
12.5.2 Tri-Prime Description and Business Overview
12.5.3 Tri-Prime Interferon Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Tri-Prime Interferon Products Offered
12.5.5 Tri-Prime Recent Development
12.6 Kawin
12.6.1 Kawin Corporation Information
12.6.2 Kawin Description and Business Overview
12.6.3 Kawin Interferon Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Kawin Interferon Products Offered
12.6.5 Kawin Recent Development
12.7 Genzon Pharma
12.7.1 Genzon Pharma Corporation Information
12.7.2 Genzon Pharma Description and Business Overview
12.7.3 Genzon Pharma Interferon Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Genzon Pharma Interferon Products Offered
12.7.5 Genzon Pharma Recent Development
12.8 Novartis
12.8.1 Novartis Corporation Information
12.8.2 Novartis Description and Business Overview
12.8.3 Novartis Interferon Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novartis Interferon Products Offered
12.8.5 Novartis Recent Development
12.9 Biogen
12.9.1 Biogen Corporation Information
12.9.2 Biogen Description and Business Overview
12.9.3 Biogen Interferon Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Biogen Interferon Products Offered
12.9.5 Biogen Recent Development
12.10 Merck KGaA
12.10.1 Merck KGaA Corporation Information
12.10.2 Merck KGaA Description and Business Overview
12.10.3 Merck KGaA Interferon Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Merck KGaA Interferon Products Offered
12.10.5 Merck KGaA Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Interferon Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Roche Interferon Products Offered
12.11.5 Roche Recent Development
12.12 Huaxin Biotechnology
12.12.1 Huaxin Biotechnology Corporation Information
12.12.2 Huaxin Biotechnology Description and Business Overview
12.12.3 Huaxin Biotechnology Interferon Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Huaxin Biotechnology Products Offered
12.12.5 Huaxin Biotechnology Recent Development
12.13 Harbin Pharmaceutical
12.13.1 Harbin Pharmaceutical Corporation Information
12.13.2 Harbin Pharmaceutical Description and Business Overview
12.13.3 Harbin Pharmaceutical Interferon Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Harbin Pharmaceutical Products Offered
12.13.5 Harbin Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Interferon Industry Trends
13.2 Interferon Market Drivers
13.3 Interferon Market Challenges
13.4 Interferon Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Interferon Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Interferon Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Long-lasting Type
Table 3. Major Manufacturers of Ordinary Type
Table 4. Global Interferon Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Interferon Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Interferon Sales by Regions (2016-2021) & (K Units)
Table 7. Global Interferon Sales Market Share by Regions (2016-2021)
Table 8. Global Interferon Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Interferon Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Interferon Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Interferon Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Interferon Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Interferon Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Interferon Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Interferon Manufacturers by Revenue (US$ Million) in 2020
Table 16. Interferon Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Interferon Revenue Share by Manufacturers (2016-2021)
Table 18. Global Interferon Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Interferon by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interferon as of 2020)
Table 20. Key Manufacturers Interferon Price (2016-2021) (USD/Unit)
Table 21. Interferon Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Interferon Product Type
Table 23. Date of International Manufacturers Enter into Interferon Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Interferon Sales by Type (2016-2021) (K Units)
Table 26. Global Interferon Sales Share by Type (2016-2021)
Table 27. Global Interferon Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Interferon Revenue Share by Type (2016-2021)
Table 29. Interferon Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global Interferon Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Interferon Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Interferon Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Interferon Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Interferon Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Interferon Sales by Application (2016-2021) (K Units)
Table 36. Global Interferon Sales Share by Application (2016-2021)
Table 37. Global Interferon Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Interferon Revenue Share by Application (2016-2021)
Table 39. Interferon Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Interferon Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Interferon Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Interferon Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Interferon Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Interferon Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. China Interferon Sales (K Units) of Key Companies (2016-2021)
Table 46. China Interferon Sales Share by Company (2016-2021)
Table 47. China Interferon Revenue (US$ Million) by Company (2016-2021)
Table 48. China Interferon Revenue Share by Company (2016-2021)
Table 49. China Interferon Sales (K Units) by Type (2016-2021)
Table 50. China Interferon Sales Share by Type (2016-2021)
Table 51. China Interferon Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Interferon Price (USD/Unit) by Type (2016-2021)
Table 53. China Interferon Sales (K Units) by Type (2022-2027)
Table 54. China Interferon Sales Share by Type (2022-2027)
Table 55. China Interferon Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Interferon Revenue Share by Type (2022-2027)
Table 57. China Interferon Price (USD/Unit) by Type (2022-2027)
Table 58. China Interferon Sales (K Units) by Application (2016-2021)
Table 59. China Interferon Sales Share by Application (2016-2021)
Table 60. China Interferon Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Interferon Price (USD/Unit) by Application (2016-2021)
Table 62. China Interferon Sales (K Units) by Application (2022-2027)
Table 63. China Interferon Sales Share by Application (2022-2027)
Table 64. China Interferon Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Interferon Revenue Share by Application (2022-2027)
Table 66. China Interferon Price (USD/Unit) by Application (2022-2027)
Table 67. North America Interferon Sales by Country (2016-2021) & (K Units)
Table 68. North America Interferon Sales Market Share by Country (2016-2021)
Table 69. North America Interferon Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Interferon Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Interferon Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Interferon Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Interferon Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Interferon Revenue Market Share by Region (2016-2021)
Table 75. Europe Interferon Sales by Country (2016-2021) & (K Units)
Table 76. Europe Interferon Sales Market Share by Country (2016-2021)
Table 77. Europe Interferon Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Interferon Revenue Market Share by Country (2016-2021)
Table 79. Latin America Interferon Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Interferon Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Interferon Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Interferon Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Interferon Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Interferon Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Interferon Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Interferon Revenue Market Share by Country (2016-2021)
Table 87. Roche Corporation Information
Table 88. Roche Description and Business Overview
Table 89. Roche Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. Roche Interferon Product
Table 91. Roche Recent Development
Table 92. Anke Biotechnology Corporation Information
Table 93. Anke Biotechnology Description and Business Overview
Table 94. Anke Biotechnology Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Anke Biotechnology Product
Table 96. Anke Biotechnology Recent Development
Table 97. Bayer Corporation Information
Table 98. Bayer Description and Business Overview
Table 99. Bayer Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. Bayer Product
Table 101. Bayer Recent Development
Table 102. Merck & Co Corporation Information
Table 103. Merck & Co Description and Business Overview
Table 104. Merck & Co Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Merck & Co Product
Table 106. Merck & Co Recent Development
Table 107. Tri-Prime Corporation Information
Table 108. Tri-Prime Description and Business Overview
Table 109. Tri-Prime Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Tri-Prime Product
Table 111. Tri-Prime Recent Development
Table 112. Kawin Corporation Information
Table 113. Kawin Description and Business Overview
Table 114. Kawin Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Kawin Product
Table 116. Kawin Recent Development
Table 117. Genzon Pharma Corporation Information
Table 118. Genzon Pharma Description and Business Overview
Table 119. Genzon Pharma Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Genzon Pharma Product
Table 121. Genzon Pharma Recent Development
Table 122. Novartis Corporation Information
Table 123. Novartis Description and Business Overview
Table 124. Novartis Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Novartis Product
Table 126. Novartis Recent Development
Table 127. Biogen Corporation Information
Table 128. Biogen Description and Business Overview
Table 129. Biogen Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Biogen Product
Table 131. Biogen Recent Development
Table 132. Merck KGaA Corporation Information
Table 133. Merck KGaA Description and Business Overview
Table 134. Merck KGaA Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. Merck KGaA Product
Table 136. Merck KGaA Recent Development
Table 137. Zydus Cadila Corporation Information
Table 138. Zydus Cadila Description and Business Overview
Table 139. Zydus Cadila Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. Zydus Cadila Product
Table 141. Zydus Cadila Recent Development
Table 142. Huaxin Biotechnology Corporation Information
Table 143. Huaxin Biotechnology Description and Business Overview
Table 144. Huaxin Biotechnology Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. Huaxin Biotechnology Product
Table 146. Huaxin Biotechnology Recent Development
Table 147. Harbin Pharmaceutical Corporation Information
Table 148. Harbin Pharmaceutical Description and Business Overview
Table 149. Harbin Pharmaceutical Interferon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 150. Harbin Pharmaceutical Product
Table 151. Harbin Pharmaceutical Recent Development
Table 152. Interferon Market Trends
Table 153. Interferon Market Drivers
Table 154. Interferon Market Challenges
Table 155. Interferon Market Restraints
Table 156. Interferon Customers List
Table 157. Interferon Distributors List
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Interferon Product Picture
Figure 2. Global Interferon Sales Market Share by Type in 2020 & 2027
Figure 3. Long-lasting Type Product Picture
Figure 4. Ordinary Type Product Picture
Figure 5. Global Interferon Sales Market Share by Application in 2020 & 2027
Figure 6. Hepatitis
Figure 7. Multiple Sclerosis
Figure 8. Others
Figure 9. Interferon Report Years Considered
Figure 10. Global Interferon Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Interferon Market Size 2016-2027 (US$ Million)
Figure 12. Global Interferon Sales 2016-2027 (K Units)
Figure 13. Global Interferon Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Interferon Sales Market Share by Region (2016-2021)
Figure 15. Global Interferon Sales Market Share by Region in 2020
Figure 16. Global Interferon Revenue Market Share by Region (2016-2021)
Figure 17. Global Interferon Revenue Market Share by Region in 2020
Figure 18. Global Interferon Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Interferon Revenue in 2020
Figure 20. Interferon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Interferon Sales Market Share by Type (2016-2021)
Figure 22. Global Interferon Sales Market Share by Type in 2020
Figure 23. Global Interferon Revenue Market Share by Type (2016-2021)
Figure 24. Global Interferon Revenue Market Share by Type in 2020
Figure 25. Global Interferon Sales Market Share by Application (2016-2021)
Figure 26. Global Interferon Sales Market Share by Application in 2020
Figure 27. Global Interferon Revenue Market Share by Application (2016-2021)
Figure 28. Global Interferon Revenue Market Share by Application in 2020
Figure 29. China Interferon Sales Growth Rate 2016-2027 (K Units)
Figure 30. China Interferon Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Interferon Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Interferon Players Market Share by Revenue in Interferon in 2020
Figure 33. China Interferon Revenue Share by Type (2016-2021)
Figure 34. China Interferon Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Interferon Revenue Share by Application (2016-2021)
Figure 36. China Interferon Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Interferon Sales Growth Rate 2016-2021 (K Units)
Figure 38. North America Interferon Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Interferon Sales Market Share by Country in 2020
Figure 40. North America Interferon Revenue Market Share by Country in 2020
Figure 41. U.S. Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 42. U.S. Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 44. Canada Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Interferon Sales Growth Rate 2016-2021 (K Units)
Figure 46. Europe Interferon Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Interferon Sales Market Share by Country in 2020
Figure 48. Europe Interferon Revenue Market Share by Country in 2020
Figure 49. Germany Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 50. Germany Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 52. France Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 54. U.K. Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 56. Italy Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 58. Russia Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Interferon Sales Growth Rate 2016-2021 (K Units)
Figure 60. Asia Pacific Interferon Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Interferon Sales Market Share by Region in 2020
Figure 62. Asia Pacific Interferon Revenue Market Share by Region in 2020
Figure 63. China Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 64. China Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 66. Japan Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 68. South Korea Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 70. India Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 72. Australia Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 74. Taiwan Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 76. Indonesia Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 78. Thailand Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 80. Malaysia Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 82. Philippines Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 84. Vietnam Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Interferon Sales Growth Rate 2016-2021 (K Units)
Figure 86. Latin America Interferon Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Interferon Sales Market Share by Country in 2020
Figure 88. Latin America Interferon Revenue Market Share by Country in 2020
Figure 89. Mexico Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 90. Mexico Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 92. Brazil Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 94. Argentina Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Interferon Sales Growth Rate 2016-2021 (K Units)
Figure 96. Middle East and Africa Interferon Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Interferon Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Interferon Revenue Market Share by Country in 2020
Figure 99. Turkey Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 100. Turkey Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 102. Saudi Arabia Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. UAE Interferon Sales Growth Rate (2016-2021) (K Units)
Figure 104. UAE Interferon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Interferon Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
インターフェロンアルファ-2aバイオシミラーの世界市場 2020年 Market Overview The Interferon Alpha-2a Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…- 長繊維熱可塑性プラスチック（LFT）の世界及び中国市場 Long Fiber Thermoplastics (LFT) is a type of easily mouldable thermoplastic used to create a variety of components used primarily in the automotive industry. Using LFT reinforcements in the thermoplastic composite process enables molders to produce structural and semi-structural parts, compounding t…
- 進行性再発型多発性硬化症（RMS）治療の世界市場 2020年 Market Overview The global Progressive Relapsing Multiple Sclerosis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019…
- インディカ（長形米）の世界及び中国市場 Rice grains were elongated or oblong shape, length 7 mm or more, less viscous, rice brittle, easily broken during processing, cross-sectional oblate, color white transparent than more, there are translucent and opaque. This report studies organic long-shaped rice market, from angles of company, regi…
- ケロイド治療の世界市場 2020年 Market Overview The global Keloid Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.9% in the forecast period of 2020 to 2025 and will expected to reach USD 3158.9 million by 2025, from USD 2929.9 million in 2019. The Keloid Treatment ma…